Cargando…
Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma
OBJECTIVE: To quantify radiation exposure and mortality risk from computed tomography (CT) and positron emission tomography (PET) imaging with (18)F-fluorodeoxyglucose ((18)F-FDG) in patients with malignant lymphoma (Hodgkin’s disease [HD] or non-Hodgkin’s lymphoma [NHL]). METHODS: First, organ dose...
Autores principales: | Nievelstein, R. A. J., Quarles van Ufford, H. M. E., Kwee, T. C., Bierings, M. B., Ludwig, I., Beek, F. J. A., de Klerk, J. M. H., Mali, W. P. Th. M., de Bruin, P. W., Geleijns, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411290/ https://www.ncbi.nlm.nih.gov/pubmed/22538627 http://dx.doi.org/10.1007/s00330-012-2447-9 |
Ejemplares similares
-
On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009) -
Whole-body diffusion-weighted imaging for staging malignant lymphoma in children
por: Kwee, Thomas C., et al.
Publicado: (2010) -
Imaging of Bone Marrow Involvement in Lymphoma: State of the Art and Future Directions
por: Kwee, Thomas C., et al.
Publicado: (2011) -
Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
por: Adams, Hugo J. A., et al.
Publicado: (2016) -
Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?
por: Adams, Hugo J. A., et al.
Publicado: (2015)